Interaction between estradiol and cAMP in the regulation of specific gene expression

Molecular and Cellular Endocrinology

Volumn 124, Issue 1-2, 1996, Pages 71-77

  El Tanani, M K K ^a   Green, C D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

cAMP; Estradiol; Gene expression

Indexed keywords

ANTIESTROGEN; CHOLERA TOXIN; CYCLIC AMP; CYCLOHEXIMIDE; ESTRADIOL; ISOBUTYLMETHYLXANTHINE;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOTROPHOBLAST; ESTROGEN METABOLISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; BREAST NEOPLASMS; CARCINOMA; CHOLERA TOXIN; CYCLIC AMP; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PHOSPHODIESTERASE INHIBITORS; POLYUNSATURATED ALKAMIDES; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RECEPTORS, ESTRADIOL; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030606115     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03930-5     Document Type: Article

References (38)

1. [1] Evans, R.M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
2. [2] Tsai, M.-J. and O'Malley, B.W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
3. [3] Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and Evans, R.M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
4. [4] Beato, M., Truss, M. and Chavez, S. (1996) Control of transcription by steroid hormones. Ann. NY Acad. Sci. 784, 93-123.
5. [5] Wakeling, A.E. and Bowler, J. (1988) Novel antioestrogens without partial agonist activity. J. Steroid Biochem. 31, 645-653.
6. [6] Berry, M., Metzger, D. and Chambon, P. (1990) Role of two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9, 2811-2818.
7. [7] Sheffield, L.G. and Welsch, C.W. (1985) Cholera-toxin-enhanced growth of human breast cancer cell lines in vitro and in vivo: interaction with estrogen. Int. J. Cancer 36, 479-483.
8. [8] Silberstein, G.B., Strickland, P., Trumpbour, V., Coleman, S. and Daniel, C.W. (1984) In vivo, cAMP stimulates growth and morphogeneis of mouse mammary ducts. Proc. Natl. Acad. Sci. USA 81, 4950-4954.
9. [9] Aronica, S.M. and Katzenellenbogen, B.S. (1991) Progesterone receptor regulation in uterine cells: stimulation by estradiol. cyclic adenosine 3′,5′-monophosphate and insulin-like growth factor-1 and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 128, 2045-2052.
10. [10] Cho, H., Aronica, S.M. and Katezenellenbogen, B.S. (1993) Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′5′-monophosphate, estradiol, insulin-like growth factor-1 and serum factors. Endocrinology 134, 658-664.
11. [11] Sumida C. and Pasqualini, J.R. (1989) Antiestrogen antagonizes the stimulatory effect of epidermal growth factor on the induction of progesterone receptor in fetal uterine cells in culture. Endocrinology 124, 591-597.
12. [12] Sumida, C. and Pasqualini, J.R. (1990) Stimulation of progesterone receptors by phorbol ester and cyclic AMP in fetal uterine cells in culture. Mol. Cell. Endocrinol. 69, 207-215.
13. [13] Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D. and Chambon, P. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
14. [14] Ignar-Trowbridge, A.M., Pimentel, M., Parker, M.G., McLachlan, J.A. and Korach, K.S. (1996) Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137, 1735-1744.
15. [15] Manning, D.L., Daly, R.J., Lord, P.G., Kelly, K.F. and Green, C.D. (1988) Effects of estrogen on the expression of a 4.4-kb mRNA in the ZR-75-1 human breast cancer cell line. Mol. Cell Endocrinol. 59, 205-212.
16. [16] Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A. and Chambon, P. (1982) Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10, 7895-7903.
17. [17] El-Tanani, M.K. and Green, C.D. (1995) Oestrogen-induced genes, pLIV-1 and pS2, respond divergently to other steroid hormones in MCF-7 cells. Mol. Cell. Endocrinol. 111, 75-81.
18. [18] Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1989) Current Protocols in Molecular Biology, Vol. 1, p. 4.10.1. Wiley Interscience, New York.
19. [19] Wilson, A.P.M., Weatherill, P.J., Nicholson, R.I., Davies, P. and Wakeling, A.E. (1990) A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164384, with the molybdate-stabilized oestrogen receptor. J. Steroid Biochem. 35, 421-428.
20. [20] Manning, D.L., McLelland, R.A., Gee, J.M.W., Chan, C.M.W., Green, C.D., Blamey, R.W. and Nicholson, R.I. (1993) The role of four oestrogen-responsive genes, pLIV-1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer. Eur. J. Cancer 29, 1462-1468.
21. [21] Brown, A.M.C., Jeltsch, J.-M., Roberts, M. and Chambon, P. (1984) Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7, Proc. Natl. Acad. Sci. USA 81, 6344-6348.
22. [22] El-Tanani, M.K.K. and Green, C.D. (1995) Hormone regulation of gene transcription in human breast cancer cells. Biochem. Soc. Trans. 23, 589S.
23. [23] Cavaillès, V., Garcia, M. and Rochefort, H. (1989) Regulation of cathepsin D and pS2 expression by growth factors in MCF-7 breast cancer cells. Mol. Endocrinol. 3, 552-558.
24. [24] El-Tanani, M.K.K. and Green, C.D. (1996) Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells. Mol. Cell. Endocrinol. 121, 29-35.
25. 1130 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79, 107-117.
26. [26] Ing, N.H., Beekman, J.M., Tsai, S.Y., Tsai, M.-J. and O'Malley, B.W. (1992) Members of the steroid hormone receptor superfamily interact with TFIIB (S300-11). J. Biol. Chem. 267, 17617-17623.
27. [27] Baniahmad, C., Nawaz, Z., Baniahmad, A., Gleeson, M.A.G., Tsai, M.-J. and O'Malley, B.W. (1995) Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol. Endocrinol. 9, 34-43.
28. [28] Guichon-Mantel, A., Savouret, J.F., Quignon, F., Delabre, K., Milgrom, E. and De The, H. (1995) Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9, 1791-1803.
29. [29] vom Baur, E., Zechel, C., Heery, D., Heine, M.J.S., Garnier, J.M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P. and Losson, R. (1995) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124.
30. [30] Cavaillès, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P.J. and Parker, M.G. (1996) Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
31. [31] Hill, C.S. and Treisman, R. (1995) Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80, 199-211.
32. [32] Gonzalez, G.A. and Montminy, M.R. (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680.
33. [33] Kiper, G.G.J.M. and Brinkman, A.O. (1994) Steroid hormone receptor phosphorylation: is there a physiological role? Mol. Cell. Endocrinol. 100, 103-107.
34. [34] Le Goff, P., Montano, M., Schodin, D.J. and Katzenellenbogen, B.S. (1994) Phosphorylation of the human estrogen receptor: identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269, 4458-4466.
35. [35] Arnold, S.F., Vorojeikina, D.P. and Notides, A.C. (1995) Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J. Biol. Chem. 270, 30205-30212.
36. [36] Lahooti, H., White, R., Hoare, S.A., Rahman, D., Pappin, D.J.C. and Parker, M.G. (1995) Identification of phosphorylation sites in the mouse oestrogen receptor. J. Steroid Biochem. Mol. Biol. 55, 305-313.
37. [37] Henderson, I.C. and Canellos, G.P. (1979) Cancer of the breast. N. Engl. J. Med. 302, 17-30.
38. [38] Katzenellenbogen, B.S. (1989) Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J. Natl. Cancer. Inst. 83, 1434-1435.